Relationship Between the Lipidome Profile and Disease Activity in Patients with Rheumatoid Arthritis-Reference-Cited by-同舟云学术

Relationship Between the Lipidome Profile and Disease Activity in Patients with Rheumatoid Arthritis

Published:2024-02-24 Issue:4 Volume:47 Page:1444-1458
ISSN:0360-3997
Container-title:Inflammation
language:en
Short-container-title:Inflammation

Author:

Masuoka Shotaro,Nishio Junko,Yamada Soichi,Saito Kosuke,Kaneko Kaichi,Kaburaki Makoto,Tanaka Nahoko,Sato Hiroshi,Muraoka Sei,Kawazoe Mai,Mizutani Satoshi,Furukawa Karin,Ishii-Watabe Akiko,Kawai Shinichi,Saito Yoshiro,Nanki Toshihiro

Funder

Toho University School of Medicine

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10753-024-01986-8.pdf

Reference32 articles.

1. McInnes, I.B., and G. Schett. 2011. The pathogenesis of rheumatoid arthritis. New England Journal of Medicine 365: 2205–2219.

2. Xue, J., L. Xu, H. Zhu, M. Bai, X. Li, Z. Zhao, H. Zhong, G. Cheng, X. Li, F. Hu, et al. 2020. CD14(+)CD16(-) monocytes are the main precursors of osteoclasts in rheumatoid arthritis via expressing Tyro3TK. Arthritis Research & Therapy 22: 221.

3. Gengenbacher, M., H.J. Sebald, P.M. Villiger, W. Hofstetter, and M. Seitz. 2008. Infliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with rheumatoid arthritis and ankylosing spondylitis. Annals of the Rheumatic Diseases 67: 620–624.

4. Shang, W., L.J. Zhao, X.L. Dong, Z.M. Zhao, J. Li, B.B. Zhang, and H. Cai. 2016. Curcumin inhibits osteoclastogenic potential in PBMCs from rheumatoid arthritis patients via the suppression of MAPK/RANK/c-Fos/NFATc1 signaling pathways. Molecular Medicine Reports 14: 3620–3626.

5. Leuti, A., D. Fazio, M. Fava, A. Piccoli, S. Oddi, and M. Maccarrone. 2020. Bioactive lipids, inflammation and chronic diseases. Advanced Drug Delivery Reviews 159: 133–169.